Acinetobacter baumannii: evolution of antimicrobial resistance—treatment options
The first decade of the 20th century witnessed a surge in the incidence of infections due to
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management
JM Pogue, T Mann, KE Barber… - Expert review of anti …, 2013 - Taylor & Francis
Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized
patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A …
patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A …
Acinetobacter baumannii: an emerging multidrug-resistant threat
TD Gootz, A Marra - Expert review of anti-infective therapy, 2008 - Taylor & Francis
Amid the recent attention focused on the growing impact of methicillin-resistant
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …
Acinetobacter baumannii: evolution of a global pathogen
LCS Antunes, P Visca, KJ Towner - Pathogens and disease, 2014 - academic.oup.com
Acinetobacter baumannii is an opportunistic nosocomial pathogen and one of the six most
important multidrug resistant microorganisms in hospitals worldwide. This human pathogen …
important multidrug resistant microorganisms in hospitals worldwide. This human pathogen …
[PDF][PDF] Acinetobacter baumannii: An Emerging Multidrug-Resistant Pathogen in Critical Care
K Montefour, J Frieden, S Hurst, C Helmich… - Critical care …, 2008 - researchgate.net
Our experience with managing an outbreak of MDR A baumannii in a medical intensive care
unit (ICU) prompted an evidence-based review of the literature, which resulted in few …
unit (ICU) prompted an evidence-based review of the literature, which resulted in few …
Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options
GM Eliopoulos, LL Maragakis… - Clinical infectious …, 2008 - academic.oup.com
Multidrug-resistant Acinetobacter baumannii is recognized to be among the most difficult
antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial …
antimicrobial-resistant gram-negative bacilli to control and treat. Increasing antimicrobial …
Infections due to Acinetobacter baumannii in the ICU
J Chastre - Seminars in respiratory and critical care medicine, 2003 - thieme-connect.com
Acinetobacter species are widespread environmental, nonfermentative, aerobic, gram-
negative coccobacilli. Most infections due to this organism are opportunistic in nature and …
negative coccobacilli. Most infections due to this organism are opportunistic in nature and …
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
R Vázquez-López, SG Solano-Gálvez… - Antibiotics, 2020 - mdpi.com
Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …
Multiresistant Acinetobacter baumannii infections: epidemiology and management
J Garnacho-Montero… - Current opinion in …, 2010 - journals.lww.com
The optimal treatment for multidrug-resistant A. baumannii nosocomial infections has not
been established. Carbapenems are the mainstay of treatment in susceptible isolates …
been established. Carbapenems are the mainstay of treatment in susceptible isolates …
[HTML][HTML] The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications
ME Falagas, EA Karveli - Clinical microbiology and infection, 2007 - Elsevier
Acinetobacter baumannii infections have become increasingly common among critically-ill
patients in intensive care units (ICUs) worldwide. A. baumannii clinical isolates are …
patients in intensive care units (ICUs) worldwide. A. baumannii clinical isolates are …